Literature DB >> 30117102

The changing landscape of thromboprophylaxis for atrial fibrillation: insights from the ISPAF-2 survey.

Giuseppe Mulè'1, Caterina Carollo2, Marco Guarneri2, Santina Cottone2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30117102     DOI： 10.1007/s11739-018-1929-4

Source DB:  PubMed          Journal:  Intern Emerg Med        ISSN： 1828-0447            Impact factor:   3.397


× No keyword cloud information.
  17 in total

1.  Italian intersociety consensus on DOAC use in internal medicine.

Authors:  Domenico Prisco; Walter Ageno; Cecilia Becattini; Armando D'Angelo; Giovanni Davì; Raimondo De Cristofaro; Francesco Dentali; Giovanni Di Minno; Anna Falanga; Gualberto Gussoni; Luca Masotti; Gualtiero Palareti; Pasquale Pignatelli; Roberto M Santi; Francesca Santilli; Mauro Silingardi; Antonella Tufano; Francesco Violi
Journal:  Intern Emerg Med       Date:  2017-02-13       Impact factor: 3.397

Review 2.  2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society.

Authors:  Craig T January; L Samuel Wann; Joseph S Alpert; Hugh Calkins; Joaquin E Cigarroa; Joseph C Cleveland; Jamie B Conti; Patrick T Ellinor; Michael D Ezekowitz; Michael E Field; Katherine T Murray; Ralph L Sacco; William G Stevenson; Patrick J Tchou; Cynthia M Tracy; Clyde W Yancy
Journal:  J Am Coll Cardiol       Date:  2014-03-28       Impact factor: 24.094

3.  2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.

Authors:  Paulus Kirchhof; Stefano Benussi; Dipak Kotecha; Anders Ahlsson; Dan Atar; Barbara Casadei; Manuel Castella; Hans-Christoph Diener; Hein Heidbuchel; Jeroen Hendriks; Gerhard Hindricks; Antonis S Manolis; Jonas Oldgren; Bogdan Alexandru Popescu; Ulrich Schotten; Bart Van Putte; Panagiotis Vardas; Stefan Agewall; John Camm; Gonzalo Baron Esquivias; Werner Budts; Scipione Carerj; Filip Casselman; Antonio Coca; Raffaele De Caterina; Spiridon Deftereos; Dobromir Dobrev; José M Ferro; Gerasimos Filippatos; Donna Fitzsimons; Bulent Gorenek; Maxine Guenoun; Stefan H Hohnloser; Philippe Kolh; Gregory Y H Lip; Athanasios Manolis; John McMurray; Piotr Ponikowski; Raphael Rosenhek; Frank Ruschitzka; Irina Savelieva; Sanjay Sharma; Piotr Suwalski; Juan Luis Tamargo; Clare J Taylor; Isabelle C Van Gelder; Adriaan A Voors; Stephan Windecker; Jose Luis Zamorano; Katja Zeppenfeld
Journal:  Europace       Date:  2016-08-27       Impact factor: 5.214

Review 4.  Global burden of atrial fibrillation in developed and developing nations.

Authors:  Sumeet S Chugh; Gregory A Roth; Richard F Gillum; George A Mensah
Journal:  Glob Heart       Date:  2014-03

5.  Projections on the number of individuals with atrial fibrillation in the European Union, from 2000 to 2060.

Authors:  Bouwe P Krijthe; Anton Kunst; Emelia J Benjamin; Gregory Y H Lip; Oscar H Franco; Albert Hofman; Jacqueline C M Witteman; Bruno H Stricker; Jan Heeringa
Journal:  Eur Heart J       Date:  2013-07-30       Impact factor: 29.983

6.  Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials.

Authors:  Christian T Ruff; Robert P Giugliano; Eugene Braunwald; Elaine B Hoffman; Naveen Deenadayalu; Michael D Ezekowitz; A John Camm; Jeffrey I Weitz; Basil S Lewis; Alexander Parkhomenko; Takeshi Yamashita; Elliott M Antman
Journal:  Lancet       Date:  2013-12-04       Impact factor: 79.321

Review 7.  New oral anticoagulants and prevention of thromboembolic events in patients with hypertension and atrial fibrillation: an appraisal.

Authors:  Claudio Borghi; Stefania Paolillo; Arrigo F G Cicero; Paola Gargiulo; Bruno Trimarco; Pasquale Perrone Filardi
Journal:  J Hypertens       Date:  2017-04       Impact factor: 4.844

Review 8.  Underuse of oral anticoagulants in atrial fibrillation: a systematic review.

Authors:  Isla M Ogilvie; Nick Newton; Sharon A Welner; Warren Cowell; Gregory Y H Lip
Journal:  Am J Med       Date:  2010-07       Impact factor: 4.965

9.  Underuse of oral anticoagulants in patients with nonvalvular atrial fibrillation in Italy.

Authors:  D Ferro; L Loffredo; L Polimeni; F Violi
Journal:  Intern Emerg Med       Date:  2007-03-31       Impact factor: 3.397

10.  Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study.

Authors:  Torben Bjerregaard Larsen; Flemming Skjøth; Peter Brønnum Nielsen; Jette Nordstrøm Kjældgaard; Gregory Y H Lip
Journal:  BMJ       Date:  2016-06-16
View more
  1 in total

1.  A focus on direct oral anticoagulants: "old" and possible new indications and efforts for a better clinical management.

Authors:  Domenico Prisco
Journal:  Intern Emerg Med       Date:  2018-09-21       Impact factor: 3.397
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.